BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 6117153)

  • 21. Behavioural disorders induced by external globus pallidus dysfunction in primates II. Anatomical study.
    François C; Grabli D; McCairn K; Jan C; Karachi C; Hirsch EC; Féger J; Tremblay L
    Brain; 2004 Sep; 127(Pt 9):2055-70. PubMed ID: 15292054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pre- and postsynaptic action of bromocriptine: its pharmacological effects on shcizophrenia and neurological diseases.
    Trabucchi M; Andreoli VM; Frattola L; Spano PF
    Adv Biochem Psychopharmacol; 1977; 16():661-5. PubMed ID: 196497
    [No Abstract]   [Full Text] [Related]  

  • 23. Some normal and abnormal behavioral syndromes due to transmitter gating of opponent processes.
    Grossberg S
    Biol Psychiatry; 1984 Jul; 19(7):1075-118. PubMed ID: 6148110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tardive dyskinesia: pathophysiology and animal models.
    Casey DE
    J Clin Psychiatry; 2000; 61 Suppl 4():5-9. PubMed ID: 10739324
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [What is the connection between Parkinson disease and tardive dyskinesia?].
    Gunne LM; Andrén PE
    Lakartidningen; 1994 Aug; 91(34):2953-5. PubMed ID: 7990538
    [No Abstract]   [Full Text] [Related]  

  • 26. Drug holiday in Huntington's disease.
    Schmidt EZ; Hofmann P; Kapfhammer HP; Bonelli RM
    Ann Pharmacother; 2005 Apr; 39(4):773. PubMed ID: 15741414
    [No Abstract]   [Full Text] [Related]  

  • 27. Hyperkinetic movement disorders misdiagnosed as tics in Gilles de la Tourette syndrome.
    Kompoliti K; Goetz CG
    Mov Disord; 1998 May; 13(3):477-80. PubMed ID: 9613740
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Voice disorders caused by neurological diseases].
    Gamboa J; Jiménez-Jiménez FJ; Mate MA; Cobeta I
    Rev Neurol; 2001 Jul 16-31; 33(2):153-68. PubMed ID: 11562877
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The subcortical regulatory motor system in the development and its disorders.
    Lesný I
    Acta Univ Carol Med Monogr; 1980; 96():1-74. PubMed ID: 7348097
    [No Abstract]   [Full Text] [Related]  

  • 30. [Hyperattentional syndrome in children].
    Grippo J; Grippo T
    Rev Neurol; 2001 Dec 16-31; 33(12):1149-51. PubMed ID: 11785053
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Neurotransmitters, drugs and neuropsychiatric diseases (author's transl)].
    Relja M; Lackvoić Z
    Lijec Vjesn; 1979 Oct; 101(10):609-16. PubMed ID: 44538
    [No Abstract]   [Full Text] [Related]  

  • 32. Transcranial magnetic stimulation in movement disorders.
    Berardelli A
    Electroencephalogr Clin Neurophysiol Suppl; 1999; 51():276-80. PubMed ID: 10590960
    [No Abstract]   [Full Text] [Related]  

  • 33. Impairment of optokinetic nystagmus in patients with tardive dyskinesia.
    Lipper S
    Arch Gen Psychiatry; 1973 Mar; 28(3):331-3. PubMed ID: 4143946
    [No Abstract]   [Full Text] [Related]  

  • 34. Attention-deficit and hyperactive neurobehavioural characteristics induced by perinatal hypothyroidism in rats.
    Negishi T; Kawasaki K; Sekiguchi S; Ishii Y; Kyuwa S; Kuroda Y; Yoshikawa Y
    Behav Brain Res; 2005 Apr; 159(2):323-31. PubMed ID: 15817195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rodent models of attention-deficit/hyperactivity disorder.
    Sagvolden T; Russell VA; Aase H; Johansen EB; Farshbaf M
    Biol Psychiatry; 2005 Jun; 57(11):1239-47. PubMed ID: 15949994
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neurobiology of attention deficit disorder with hyperactivity: where have we come in 50 years?
    Zametkin AJ; Rapoport JL
    J Am Acad Child Adolesc Psychiatry; 1987 Sep; 26(5):676-86. PubMed ID: 2889717
    [No Abstract]   [Full Text] [Related]  

  • 37. [A reversible disorder of the avoidance reaction as an experimental model for the study of the action of psychotropic preparations on higher nervous activity].
    Inozemtsev AN; Pragina LL
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1989; 39(4):764-6. PubMed ID: 2816063
    [No Abstract]   [Full Text] [Related]  

  • 38. Basal ganglia disease.
    Marsden CD
    Lancet; 1982 Nov; 2(8308):1141-7. PubMed ID: 6128460
    [No Abstract]   [Full Text] [Related]  

  • 39. Priming for L-DOPA-induced abnormal involuntary movements increases the severity of amphetamine-induced dyskinesia in grafted rats.
    Lane EL; Vercammen L; Cenci MA; Brundin P
    Exp Neurol; 2009 Sep; 219(1):355-8. PubMed ID: 19393238
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Neurobiology of attention deficit-hyperactivity disorder].
    Narbona-García J; Sánchez-Carpintero R
    Rev Neurol; 1999 Feb; 28 Suppl 2():S160-4. PubMed ID: 10778507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.